Search Prime Grants

UH3HL165065

Cooperative Agreement

Overview

Grant Description
The rhythm evaluation for anticoagulation with continuous monitoring of atrial fibrillation trial (REACT-AF).
Awardee
Northwestern University
Funding Goals
TO FOSTER HEART AND VASCULAR RESEARCH IN THE BASIC, TRANSLATIONAL, CLINICAL AND POPULATION SCIENCES, AND TO FOSTER TRAINING TO BUILD TALENTED YOUNG INVESTIGATORS IN THESE AREAS, FUNDED THROUGH COMPETITIVE RESEARCH TRAINING GRANTS. SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAM: TO STIMULATE TECHNOLOGICAL INNOVATION, USE SMALL BUSINESS TO MEET FEDERAL RESEARCH AND DEVELOPMENT NEEDS, FOSTER AND ENCOURAGE PARTICIPATION IN INNOVATION AND ENTREPRENEURSHIP BY SOCIALLY AND ECONOMICALLY DISADVANTAGED PERSONS, AND INCREASE PRIVATE-SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT FUNDING. SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM: TO STIMULATE TECHNOLOGICAL INNOVATION, FOSTER TECHNOLOGY TRANSFER THROUGH COOPERATIVE R&D BETWEEN SMALL BUSINESSES AND RESEARCH INSTITUTIONS, AND INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL R&D.
Grant Program (CFDA)
93.837 - Cardiovascular Diseases Research
Awarding / Funding Agency
National Heart Lung and Blood Institute (NHLBI) [HHS - NIH]
Place of Performance
Chicago, Illinois 606112908 United States
Geographic Scope
Single Zip Code
Related Opportunity
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) (PAR-19-329)
Analysis Notes
Amendment Since initial award the total obligations have increased 948% from $1,268,896 to $13,302,912.
Northwestern University was awarded Cooperative Agreement UH3HL165065 worth $13,302,912 from National Heart Lung and Blood Institute in August 2022 with work to be completed primarily in Chicago Illinois United States. The grant has a duration of 7 years and was awarded through assistance program 93.837 Cardiovascular Diseases Research. The Cooperative Agreement was awarded through grant opportunity Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required).

Status
(Ongoing)

Last Modified 12/17/24

Period of Performance
8/25/22
Start Date
7/31/29
End Date
39.0% Complete

Funding Split
$13.3M
Federal Obligation
$0.0
Non-Federal Obligation
$13.3M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to UH3HL165065

Subgrant Awards

Disclosed subgrants for UH3HL165065

Transaction History

Modifications to UH3HL165065

Additional Detail

Award ID FAIN
UH3HL165065
SAI Number
UH3HL165065-503350079
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NH00 NIH NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
Funding Office
75NH00 NIH NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
Awardee UEI
KG76WYENL5K1
Awardee CAGE
01725
Performance District
IL-05
Senators
Richard Durbin
Tammy Duckworth

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Heart, Lung, and Blood Institute, National Institutes of Health, Health and Human Services (075-0872) Health research and training Grants, subsidies, and contributions (41.0) $5,075,586 80%
National Institute of Neurological Disorders and Stroke, National Institutes of Health, Health and Human Services (075-0886) Health research and training Grants, subsidies, and contributions (41.0) $1,268,896 20%
Modified: 12/17/24